hydralazine and nitroarginine

hydralazine has been researched along with nitroarginine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaudhuri, G; Cuevas, JM; Ignarro, LJ; Vargas, HM1
Boura, AL; Leitch, IM; Read, MA; Walters, WA1
Fujino, H; Ikeda, K; Kubota, A; Nara, Y; Numano, F; Tagami, M; Yamori, Y1
Hajj-Ali, AF; Reilly, TM; Wong, PC1
Bennett, MA; Hillier, C; Thurston, H1
Goto, K; Kasuya, Y; Kimura, S; Masaki, T; Wei, S; Yanagisawa, M1
Ikeda, K; Nara, Y; Tagami, M; Yamori, Y1

Other Studies

7 other study(ies) available for hydralazine and nitroarginine

ArticleYear
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:3

    Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Hydralazine; In Vitro Techniques; Male; Nitrates; Nitric Acid; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Penicillamine; Phenylephrine; Rats; Rats, Inbred Strains; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System; Vasodilation; Vasopressins

1991
Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Amino Acid Oxidoreductases; Aminoquinolines; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Embryonic and Fetal Development; Female; Guanylate Cyclase; Heart Rate, Fetal; Humans; Hydralazine; In Vitro Techniques; Linear Models; Nitric Oxide Synthase; Nitroarginine; Perfusion; Placenta; Potassium Chloride; Pregnancy; Vasoconstriction; Vasodilation

1994
Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
    Laboratory investigation; a journal of technical methods and pathology, 1995, Volume: 72, Issue:2

    Topics: Animals; Arginine; Arterial Occlusive Diseases; Blood Pressure; Blood Vessels; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hydralazine; Hypertension, Renovascular; Incidence; Microscopy, Electron; Nitric Oxide; Nitroarginine; Potassium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium; Thrombosis; Time Factors; Vascular Diseases

1995
Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Antibodies; Arginine; Biphenyl Compounds; Drug Interactions; Hemodynamics; Hydralazine; Imidazoles; Kidney; Losartan; Male; Nitroarginine; Prazosin; Rabbits; Tetrazoles; Vasoconstrictor Agents

1994
Endothelium-dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long-term treatment with perindopril, quinapril, hydralazine or amlodipine.
    Journal of hypertension, 1996, Volume: 14, Issue:3

    Topics: Acetylcholine; Amlodipine; Animals; Antihypertensive Agents; Arginine; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Hydralazine; Hypertension; Indoles; Isoquinolines; Mesenteric Arteries; Nitroarginine; Perindopril; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrahydroisoquinolines; Vasodilation

1996
Studies on endothelium-dependent vasorelaxation by hydralazine in porcine coronary artery.
    European journal of pharmacology, 1997, Mar-05, Volume: 321, Issue:3

    Topics: Animals; Coronary Vessels; Cyclic AMP; Cyclic GMP; Cyclooxygenase Inhibitors; Dactinomycin; Endothelium; Hemoglobins; Hydralazine; In Vitro Techniques; Indomethacin; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Protein Synthesis Inhibitors; Swine; Vasodilator Agents

1997
Nitric oxide deficiency induces myocardial infarction in hypercholesterolaemic stroke-prone spontaneously hypertensive rats.
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:5

    Topics: Animals; Blood Pressure; Cerebrovascular Disorders; Coronary Vessels; Enzyme Inhibitors; Fibrosis; Hydralazine; Hypercholesterolemia; Male; Myocardial Infarction; Myocardium; Necrosis; Nitric Oxide; Nitroarginine; Rats; Rats, Inbred SHR

1997